Carol Anne Paronis, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cannabinoids | 8 | 2022 | 174 | 3.060 |
Why?
|
| Receptor, Cannabinoid, CB1 | 12 | 2021 | 137 | 1.900 |
Why?
|
| Naltrexone | 10 | 2024 | 319 | 1.670 |
Why?
|
| Receptors, Opioid, mu | 11 | 2024 | 171 | 1.600 |
Why?
|
| Cannabinol | 4 | 2016 | 9 | 1.190 |
Why?
|
| Diuretics | 3 | 2016 | 614 | 1.090 |
Why?
|
| Discrimination Learning | 6 | 2021 | 278 | 1.000 |
Why?
|
| Adamantane | 3 | 2016 | 148 | 0.970 |
Why?
|
| Alkaloids | 2 | 2021 | 192 | 0.860 |
Why?
|
| Morphine | 15 | 2023 | 658 | 0.810 |
Why?
|
| Dose-Response Relationship, Drug | 29 | 2024 | 10760 | 0.780 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2021 | 69 | 0.760 |
Why?
|
| Narcotic Antagonists | 9 | 2024 | 591 | 0.760 |
Why?
|
| Conditioning, Operant | 5 | 2014 | 308 | 0.760 |
Why?
|
| Methamphetamine | 3 | 2021 | 167 | 0.710 |
Why?
|
| Reinforcement Schedule | 4 | 2013 | 123 | 0.700 |
Why?
|
| Central Nervous System Stimulants | 4 | 2021 | 1168 | 0.690 |
Why?
|
| Saimiri | 12 | 2021 | 337 | 0.690 |
Why?
|
| Analgesics, Opioid | 8 | 2024 | 3837 | 0.690 |
Why?
|
| Drug Partial Agonism | 1 | 2019 | 24 | 0.670 |
Why?
|
| Behavior, Addictive | 2 | 2019 | 428 | 0.640 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2018 | 32 | 0.640 |
Why?
|
| Drug Tolerance | 6 | 2016 | 365 | 0.630 |
Why?
|
| Buprenorphine | 3 | 2019 | 667 | 0.600 |
Why?
|
| Piperidines | 5 | 2022 | 1667 | 0.600 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2018 | 151 | 0.590 |
Why?
|
| Receptors, Opioid, kappa | 2 | 2016 | 136 | 0.580 |
Why?
|
| Lip | 1 | 2018 | 196 | 0.550 |
Why?
|
| Self Administration | 9 | 2021 | 386 | 0.540 |
Why?
|
| Nitrates | 1 | 2018 | 260 | 0.530 |
Why?
|
| Psychotropic Drugs | 1 | 2021 | 881 | 0.510 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2023 | 628 | 0.510 |
Why?
|
| Midazolam | 4 | 2007 | 267 | 0.500 |
Why?
|
| Pyrazoles | 4 | 2022 | 2028 | 0.430 |
Why?
|
| Central Nervous System Depressants | 1 | 2013 | 163 | 0.410 |
Why?
|
| Behavior, Animal | 7 | 2021 | 1862 | 0.380 |
Why?
|
| Pain Measurement | 6 | 2019 | 3583 | 0.380 |
Why?
|
| Cocaine | 5 | 2021 | 947 | 0.360 |
Why?
|
| Receptors, GABA-A | 3 | 2006 | 625 | 0.360 |
Why?
|
| Milk | 1 | 2013 | 438 | 0.350 |
Why?
|
| Oxycodone | 2 | 2024 | 144 | 0.350 |
Why?
|
| GABA Modulators | 3 | 2006 | 109 | 0.350 |
Why?
|
| Benzopyrans | 3 | 2018 | 63 | 0.350 |
Why?
|
| Receptors, Opioid, delta | 3 | 2022 | 48 | 0.340 |
Why?
|
| Receptors, Dopamine D1 | 3 | 2007 | 277 | 0.340 |
Why?
|
| Animals | 49 | 2023 | 169246 | 0.320 |
Why?
|
| Morphinans | 2 | 2023 | 27 | 0.320 |
Why?
|
| Dopamine Agonists | 2 | 2007 | 347 | 0.300 |
Why?
|
| GABA-A Receptor Agonists | 3 | 2003 | 86 | 0.300 |
Why?
|
| Blinking | 2 | 2007 | 135 | 0.290 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2018 | 8128 | 0.290 |
Why?
|
| Drug Interactions | 6 | 2018 | 1419 | 0.280 |
Why?
|
| Ethanol | 1 | 2013 | 1331 | 0.280 |
Why?
|
| Benzazepines | 3 | 2007 | 308 | 0.280 |
Why?
|
| Benzodiazepines | 2 | 2006 | 1138 | 0.270 |
Why?
|
| Punishment | 1 | 2007 | 95 | 0.270 |
Why?
|
| Hypnotics and Sedatives | 2 | 2007 | 1191 | 0.270 |
Why?
|
| Morphine Dependence | 2 | 2023 | 27 | 0.260 |
Why?
|
| Rats | 18 | 2022 | 23760 | 0.260 |
Why?
|
| Narcotics | 4 | 2023 | 332 | 0.260 |
Why?
|
| Macaca mulatta | 10 | 2021 | 2363 | 0.240 |
Why?
|
| Respiration | 4 | 2000 | 1665 | 0.230 |
Why?
|
| Pyrrolidines | 3 | 2021 | 340 | 0.230 |
Why?
|
| Benzodioxoles | 2 | 2021 | 80 | 0.230 |
Why?
|
| Drug-Seeking Behavior | 1 | 2024 | 45 | 0.220 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2005 | 186 | 0.220 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 2 | 2022 | 58 | 0.200 |
Why?
|
| Serotonin 5-HT1 Receptor Agonists | 1 | 2022 | 42 | 0.200 |
Why?
|
| Propiophenones | 1 | 2021 | 28 | 0.190 |
Why?
|
| Morphine Derivatives | 2 | 2000 | 43 | 0.190 |
Why?
|
| Cinnamates | 2 | 2000 | 59 | 0.190 |
Why?
|
| Naloxone | 3 | 1994 | 372 | 0.180 |
Why?
|
| Tremor | 1 | 2022 | 197 | 0.180 |
Why?
|
| Morpholines | 3 | 2012 | 584 | 0.180 |
Why?
|
| Macaca | 1 | 2022 | 413 | 0.180 |
Why?
|
| Hydromorphone | 1 | 2020 | 70 | 0.170 |
Why?
|
| Mice | 12 | 2023 | 82029 | 0.170 |
Why?
|
| Pyridines | 2 | 2022 | 2894 | 0.170 |
Why?
|
| Acetamides | 1 | 2001 | 259 | 0.170 |
Why?
|
| Receptors, Opioid | 3 | 2022 | 145 | 0.160 |
Why?
|
| Naphthalenes | 2 | 2012 | 198 | 0.160 |
Why?
|
| Receptor, Cannabinoid, CB2 | 3 | 2013 | 48 | 0.160 |
Why?
|
| Substance-Related Disorders | 2 | 2006 | 4423 | 0.160 |
Why?
|
| Structure-Activity Relationship | 7 | 2021 | 3055 | 0.160 |
Why?
|
| Hypercapnia | 1 | 2020 | 259 | 0.160 |
Why?
|
| Sleep, REM | 1 | 2022 | 595 | 0.160 |
Why?
|
| Benzoxazines | 2 | 2012 | 320 | 0.150 |
Why?
|
| Enkephalins | 1 | 1997 | 139 | 0.140 |
Why?
|
| Imidazoles | 1 | 2003 | 1169 | 0.140 |
Why?
|
| Receptors, Cannabinoid | 1 | 2016 | 43 | 0.130 |
Why?
|
| Water | 2 | 2013 | 1421 | 0.130 |
Why?
|
| Kinetics | 3 | 2018 | 6329 | 0.130 |
Why?
|
| Reaction Time | 2 | 2003 | 2101 | 0.130 |
Why?
|
| Male | 30 | 2022 | 364719 | 0.130 |
Why?
|
| Hypothermia | 2 | 2013 | 189 | 0.110 |
Why?
|
| Benzeneacetamides | 1 | 1993 | 36 | 0.110 |
Why?
|
| Benzamides | 2 | 2014 | 1379 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2022 | 1240 | 0.110 |
Why?
|
| Analgesia | 3 | 2010 | 460 | 0.110 |
Why?
|
| Anticonvulsants | 1 | 2003 | 1923 | 0.100 |
Why?
|
| Meperidine | 1 | 1992 | 37 | 0.100 |
Why?
|
| Electrolytes | 1 | 2013 | 279 | 0.100 |
Why?
|
| Body Temperature | 2 | 2013 | 780 | 0.100 |
Why?
|
| Diuresis | 1 | 2012 | 107 | 0.100 |
Why?
|
| Fentanyl | 3 | 1992 | 451 | 0.100 |
Why?
|
| Analgesics | 4 | 2013 | 1071 | 0.100 |
Why?
|
| Levorphanol | 2 | 2010 | 9 | 0.100 |
Why?
|
| Arachidonic Acids | 1 | 2012 | 296 | 0.100 |
Why?
|
| Food | 3 | 2007 | 768 | 0.100 |
Why?
|
| Recurrence | 1 | 2024 | 8509 | 0.090 |
Why?
|
| Injections, Intramuscular | 2 | 2003 | 556 | 0.090 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2010 | 19 | 0.090 |
Why?
|
| Flumazenil | 2 | 2001 | 84 | 0.090 |
Why?
|
| Injections, Intravenous | 2 | 2003 | 1377 | 0.090 |
Why?
|
| Biogenic Monoamines | 1 | 2010 | 50 | 0.090 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2005 | 3729 | 0.080 |
Why?
|
| Infusion Pumps | 2 | 2005 | 163 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2001 | 3048 | 0.080 |
Why?
|
| Choice Behavior | 2 | 2006 | 848 | 0.080 |
Why?
|
| Cerebellum | 1 | 2016 | 1522 | 0.080 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 2188 | 0.080 |
Why?
|
| Binding, Competitive | 2 | 2020 | 1142 | 0.080 |
Why?
|
| Carbolines | 2 | 2001 | 295 | 0.080 |
Why?
|
| Desipramine | 2 | 2005 | 183 | 0.070 |
Why?
|
| Rats, Inbred Strains | 4 | 1992 | 2087 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2003 | 4530 | 0.070 |
Why?
|
| Piperazines | 3 | 2014 | 2554 | 0.070 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2006 | 50 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2012 | 2923 | 0.070 |
Why?
|
| Time Factors | 7 | 2013 | 40218 | 0.070 |
Why?
|
| Electroencephalography | 1 | 2022 | 6314 | 0.070 |
Why?
|
| Sleep | 1 | 2022 | 4819 | 0.060 |
Why?
|
| Smoking | 1 | 2003 | 9092 | 0.060 |
Why?
|
| Methylphenidate | 2 | 2010 | 480 | 0.060 |
Why?
|
| Female | 16 | 2021 | 397192 | 0.060 |
Why?
|
| Models, Molecular | 4 | 2020 | 5403 | 0.060 |
Why?
|
| Dextroamphetamine | 1 | 2005 | 132 | 0.060 |
Why?
|
| Propylamines | 1 | 2005 | 161 | 0.060 |
Why?
|
| Nordazepam | 1 | 2003 | 5 | 0.050 |
Why?
|
| Depression | 1 | 2003 | 8230 | 0.050 |
Why?
|
| Heroin | 2 | 2000 | 120 | 0.050 |
Why?
|
| Dopamine Agents | 1 | 2003 | 188 | 0.050 |
Why?
|
| Dopamine | 1 | 2010 | 1592 | 0.050 |
Why?
|
| Serotonin Antagonists | 1 | 2003 | 147 | 0.050 |
Why?
|
| Vocalization, Animal | 1 | 2003 | 95 | 0.050 |
Why?
|
| Homeostasis | 1 | 2013 | 3348 | 0.050 |
Why?
|
| Diazepam | 1 | 2003 | 214 | 0.050 |
Why?
|
| Nitrogen | 1 | 2023 | 345 | 0.050 |
Why?
|
| Receptors, Serotonin | 1 | 2003 | 211 | 0.050 |
Why?
|
| Ligands | 2 | 2022 | 3284 | 0.050 |
Why?
|
| Internal-External Control | 1 | 2003 | 348 | 0.050 |
Why?
|
| HEK293 Cells | 3 | 2016 | 4283 | 0.050 |
Why?
|
| GABA Antagonists | 1 | 2001 | 119 | 0.050 |
Why?
|
| Pentanones | 1 | 2021 | 12 | 0.050 |
Why?
|
| Levodopa | 1 | 2022 | 221 | 0.050 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2003 | 471 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 1141 | 0.050 |
Why?
|
| Molecular Structure | 2 | 2016 | 1883 | 0.040 |
Why?
|
| Avoidance Learning | 2 | 2010 | 248 | 0.040 |
Why?
|
| Motor Activity | 1 | 2010 | 2711 | 0.040 |
Why?
|
| Benzodiazepinones | 1 | 1999 | 50 | 0.040 |
Why?
|
| CHO Cells | 1 | 2022 | 1379 | 0.040 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 1999 | 59 | 0.040 |
Why?
|
| Electroshock | 1 | 1999 | 120 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 1534 | 0.040 |
Why?
|
| Heroin Dependence | 1 | 2000 | 173 | 0.040 |
Why?
|
| Extinction, Psychological | 1 | 2002 | 367 | 0.040 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2021 | 326 | 0.040 |
Why?
|
| Cricetinae | 1 | 2022 | 2423 | 0.040 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2021 | 417 | 0.040 |
Why?
|
| Eating | 1 | 2005 | 1542 | 0.040 |
Why?
|
| Protein Binding | 2 | 2021 | 9343 | 0.040 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1997 | 19 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 1994 | 2230 | 0.040 |
Why?
|
| Brain | 1 | 2005 | 27360 | 0.040 |
Why?
|
| Stereoisomerism | 2 | 2010 | 612 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2003 | 951 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 1037 | 0.040 |
Why?
|
| Membranes | 1 | 1997 | 164 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2709 | 0.040 |
Why?
|
| Humans | 11 | 2024 | 768166 | 0.040 |
Why?
|
| Tobacco Use Disorder | 1 | 2003 | 708 | 0.030 |
Why?
|
| Generalization, Stimulus | 1 | 1994 | 13 | 0.030 |
Why?
|
| Cisterna Magna | 1 | 1993 | 39 | 0.030 |
Why?
|
| Arrestin | 1 | 2013 | 30 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2014 | 380 | 0.030 |
Why?
|
| Motivation | 1 | 2003 | 2020 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 3711 | 0.030 |
Why?
|
| Oxygen | 1 | 2023 | 4270 | 0.020 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1991 | 158 | 0.020 |
Why?
|
| Binding Sites | 1 | 1999 | 6020 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 1992 | 687 | 0.020 |
Why?
|
| Injections | 1 | 1993 | 840 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2010 | 116 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2010 | 366 | 0.020 |
Why?
|
| Microdialysis | 1 | 2010 | 156 | 0.020 |
Why?
|
| Drug Design | 1 | 2014 | 1046 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2013 | 1470 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2726 | 0.020 |
Why?
|
| Prosencephalon | 1 | 2010 | 305 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 1951 | 0.020 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2010 | 287 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2010 | 563 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1991 | 1760 | 0.020 |
Why?
|
| Nucleus Accumbens | 1 | 2010 | 358 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 1999 | 3205 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 18349 | 0.020 |
Why?
|
| Hypothermia, Induced | 1 | 2010 | 754 | 0.020 |
Why?
|
| Spleen | 1 | 2010 | 2295 | 0.010 |
Why?
|
| Vesicular Biogenic Amine Transport Proteins | 1 | 2003 | 9 | 0.010 |
Why?
|
| Helplessness, Learned | 1 | 2003 | 24 | 0.010 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2003 | 36 | 0.010 |
Why?
|
| Columbidae | 1 | 2003 | 40 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1992 | 6229 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2003 | 584 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2003 | 1310 | 0.010 |
Why?
|
| Body Weight | 1 | 1992 | 4627 | 0.010 |
Why?
|
| Citalopram | 1 | 2003 | 401 | 0.010 |
Why?
|
| Drug Antagonism | 1 | 2000 | 50 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 15597 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 2000 | 1148 | 0.010 |
Why?
|
| Risk Factors | 1 | 2003 | 74944 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 223646 | 0.000 |
Why?
|
| Methadone | 1 | 1990 | 317 | 0.000 |
Why?
|